Segmentation & Targeting Optimisation

A Life Sciences organisation faced limitations in how healthcare professionals (HCPs) were segmented and prioritised for field engagement. Target lists were built using static datasets that were manually refreshed at periodic intervals. These lists were primarily based on historical prescribing volumes and broad territory assignments, without incorporating dynamic engagement signals or market access shifts.

As prescribing behaviours evolved and access conditions changed, segmentation models failed to adapt quickly. Field representatives continued to allocate effort toward low-potential HCPs while emerging growth opportunities were not systematically prioritised. This led to inefficient coverage, uneven territory performance and suboptimal commercial returns.

Additionally, there was limited visibility into how engagement patterns influenced prescribing trends. Commercial teams lacked predictive insights to guide next-best actions or recommend optimal focus areas. The organisation required a dynamic, data-driven segmentation framework capable of continuously adjusting to real-time commercial signals.

A multi-dimensional segmentation and targeting model was implemented using Salesforce Data Cloud (Data 360) as the central data foundation.

The new segmentation framework incorporated prescribing data, engagement history, digital interaction signals and market access indicators. Instead of relying on static tiers, HCP segments were dynamically refreshed using real-time data inputs. This ensured that targeting reflected current performance trends and growth potential.

Agentforce 360 was deployed to operationalise insights across commercial workflows. Predictive analytics models were introduced to identify HCPs with rising potential, declining engagement or competitive risk exposure. These insights were translated into prioritisation recommendations at the territory level.

Agentforce Sales (Salesforce Sales Cloud) embedded these recommendations directly into field workflows. Representatives received guidance on next-best actions, optimal call frequency and focus alignment based on capacity and territory objectives.

Territory-level planning was recalibrated to balance sales capacity with segment potential. Low-value engagement efforts were reduced, while high-potential accounts received structured and consistent focus.

The solution shifted targeting from periodic review cycles to continuous optimisation.

How AI-Powered HCP Segmentation & Targeting Works

What is HCP segmentation

HCP segmentation is the process of grouping healthcare professionals into distinct categories based on shared characteristics such as prescribing behaviour, specialty, patient population and engagement patterns. Segmentation gives commercial teams a structured way to understand which HCPs behave similarly and which require different engagement strategies.

Why HCP segmentation matters in Life Sciences

Life Sciences organisations operate with limited field capacity and strict compliance boundaries. Segmentation allows commercial teams to direct limited resources toward HCPs with the greatest potential impact, rather than spreading effort evenly across a territory regardless of opportunity.

Segmentation versus targeting

Segmentation and targeting are related but distinct steps in the commercial workflow. Segmentation groups HCPs into categories based on shared traits. Targeting takes those segments and prioritises specific HCPs for engagement based on potential, capacity and business objectives. The broader flow follows this sequence:

• HCP data is unified
• HCPs are segmented into groups
• Segments are scored and prioritised through targeting
• Territories are aligned to targeting priorities
• Engagement is planned and executed
• Next-best actions are recommended
• Outcomes are measured
• Segmentation and targeting are continuously optimised based on results

Static versus dynamic HCP segmentation

Static segmentation relies on periodic manual refreshes, typically built from historical prescribing volumes and fixed territory assignments. It does not adjust as HCP behaviour or market access conditions change, which leads to outdated targeting between refresh cycles.

Dynamic segmentation continuously updates HCP segments using real-time data inputs such as current prescribing trends, engagement signals and access changes. This allows commercial teams to react to shifts in HCP behaviour as they happen rather than waiting for the next scheduled review.

How often HCP segments should be refreshed

Under a dynamic model, segments are not refreshed on a fixed calendar cycle. Instead, they update continuously as new data flows in through Data 360, so targeting always reflects current conditions rather than a snapshot from weeks or months earlier.

Segmentation criteria used in this framework

The segmentation model draws on a combination of signals rather than a single data point. Criteria incorporated into the framework include:

• Prescribing behaviour and volume
• Prescribing growth or decline trends
• HCP specialty
• Patient population characteristics
• Engagement history with field representatives
• Digital interaction signals
• Channel preference
• Market access conditions
• Territory and geographic factors
• Competitive activity in the HCP's practice
• Recent changes in prescribing behaviour

These signals are combined to produce a fuller view of each HCP rather than relying solely on historical volume.

Unified HCP data through Data 360

Data 360 (Salesforce Data Cloud) serves as the central data foundation for the framework. It consolidates prescribing data, engagement history, digital signals and market access indicators into a unified HCP profile. This unified view is what allows segmentation to move beyond static, siloed datasets and reflect a complete picture of each HCP.

How AI identifies high-potential HCPs

Predictive analytics models evaluate patterns across the unified HCP data to identify HCPs showing rising potential, such as increasing prescribing trends or growing engagement responsiveness, and surface them as priority candidates for field focus.

How AI detects declining engagement and competitive risk

The same predictive models monitor for signals that indicate a weakening relationship, such as reduced engagement responsiveness or prescribing patterns that suggest competitive activity. These HCPs are flagged so representatives can address the risk before it affects prescribing outcomes.

How AI supports next-best-action recommendations

Agentforce 360 translates predictive insights into specific, actionable recommendations. Rather than leaving representatives to interpret raw data, the system recommends the next-best action for a given HCP, along with guidance on optimal call frequency and focus alignment based on the representative's territory and capacity.

How territory optimisation works within the framework

Territory planning is recalibrated using segment potential alongside sales capacity. Instead of dividing effort evenly across a territory, capacity is weighted toward higher-potential segments, while low-value engagement effort is reduced. This keeps territory coverage aligned with where the opportunity actually is.

Omnichannel HCP engagement

The framework incorporates digital interaction signals alongside field engagement, recognising that HCPs interact with commercial teams through more than in-person visits. Digital engagement, campaign response and channel preference feed into the same unified profile used for segmentation, allowing engagement strategy to reflect how a given HCP prefers to be reached rather than defaulting to a single channel.

How Data 360 and Agentforce work together

The relationship between the platforms follows a clear data-to-action architecture:

• Data 360 unifies prescribing, engagement, digital and market access data into a single HCP profile
• Agentforce 360 applies predictive analytics to that unified data to generate insights and prioritisation recommendations
• Agentforce Sales (Salesforce Sales Cloud) embeds those recommendations directly into field representative workflows
• Representative activity and outcomes feed back into the system, supporting continuous refinement of segmentation and targeting

Data governance and responsible use of HCP data

Because the framework relies on prescribing and engagement data, it operates within the data governance and compliance boundaries expected in a Life Sciences commercial environment. Unifying data through Data 360 also supports better data quality and consistency, since HCP information is maintained in a single governed profile rather than scattered across disconnected systems. Applying AI to commercial targeting in this context calls for the same standards of appropriate use, auditability and responsible handling of HCP data that apply to any Life Sciences commercial process.

Measuring the impact of segmentation and targeting

Rather than relying only on periodic historical reporting, the framework enables ongoing measurement of how segmentation and targeting decisions translate into commercial outcomes. Sales leadership gained clearer visibility into territory performance drivers and segment movement trends, shifting the team from reacting to past reports toward proactively adjusting engagement strategy based on forward-looking signals.

Targeting accuracy improved significantly as dynamic segmentation replaced static lists. Field effort was redistributed toward high-growth opportunities, improving overall commercial effectiveness.

Campaign performance improved due to better alignment between segmentation logic and engagement strategy. Predictive insights reduced wasted effort on low-potential HCPs and strengthened coverage consistency within priority segments.

Sales leadership gained clearer visibility into territory performance drivers and segment movement trends. Instead of reacting to historical reports, teams were able to proactively adjust engagement strategies based on forward-looking signals.

The organisation established a scalable targeting framework capable of supporting advanced AI-driven optimisation and continuous commercial refinement.

Business Impact

• 25% increase in target accuracy
• 20% increase in campaign effectiveness
• 30% reduction in effort on low-potential HCPs

Technology Stack

• Data 360 (Salesforce Data Cloud)
• Agentforce 360 (Salesforce AI Capabilities)
• Agentforce Sales (Salesforce Sales Cloud)

Frequently Asked Questions

What is HCP segmentation?

HCP segmentation is the process of grouping healthcare professionals into categories based on shared characteristics such as prescribing behaviour, specialty, engagement history and patient population, so commercial teams can apply differentiated engagement strategies.

How does dynamic HCP segmentation work?

Dynamic HCP segmentation continuously updates segment assignments using real-time data such as current prescribing trends, engagement signals and market access changes, rather than relying on a periodically refreshed static list.

What is the difference between HCP segmentation and targeting?

Segmentation groups HCPs based on shared traits, while targeting uses those segments to prioritise specific HCPs for engagement based on potential, capacity and business objectives.

What data is used for HCP segmentation?

Segmentation draws on prescribing data, engagement history, digital interaction signals, market access indicators, specialty, territory factors and competitive activity, unified through Data 360.

How does Salesforce Data Cloud help Life Sciences companies?

Data 360 consolidates prescribing, engagement, digital and market access data into a single unified HCP profile, giving commercial teams a complete and current view of each HCP instead of fragmented, siloed data.

How does AI improve HCP targeting?

AI applies predictive analytics to unified HCP data to identify rising-potential HCPs, flag declining engagement or competitive risk, and generate next-best-action recommendations that guide field representatives toward the highest-impact activities.

How does Agentforce support Life Sciences sales teams?

Agentforce 360 generates predictive insights and prioritisation recommendations from unified HCP data, while Agentforce Sales embeds those recommendations directly into representative workflows, including next-best action and optimal call frequency guidance.

How can pharmaceutical companies optimise HCP engagement?

Pharmaceutical companies can optimise HCP engagement by unifying HCP data across channels, applying dynamic segmentation instead of static lists, using predictive analytics to prioritise high-potential HCPs, and incorporating digital and field engagement signals into a single, continuously updated profile.